Page last updated: 2024-12-10

undecaprenyl phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

undecaprenyl phosphate: RN's in Chemline for diphosphate esters: 31589-58-9, 31867-59-1 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5283548
CHEBI ID60468
SCHEMBL ID169443
MeSH IDM0054475

Synonyms (10)

Synonym
undecaprenyl phosphate
LMPR03020001
3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2z,6z,10z,14z,18z,22z,26z,30z,34e,38e,42-undecaen-1-yl phosphate
ditrans,octacis-undecaprenyl phosphate
(2z,6z,10z,14z,18z,22z,26z,30z,34e,38e)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-yl dihydrogen phosphate
CHEBI:60468
C17556
[(2z,6z,10z,14z,18z,22z,26z,30z,34e,38e)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaenyl] dihydrogen phosphate
SCHEMBL169443
Q27127302
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
undecaprenyl phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (10.26)18.7374
1990's4 (10.26)18.2507
2000's11 (28.21)29.6817
2010's13 (33.33)24.3611
2020's7 (17.95)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (17.95%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (82.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]